Articles with public access mandates - Sandra Rodriguez-PeralesLearn more
OverallGovernment of SpainEuropean CommissionBanking Foundation "la Caixa"NIHDFGBBSRCBMBFNSFCEMBLSwedish Research CouncilEPSRCMRCWorldwide Cancer Research, UKResearch Grants Council, Hong KongAXA Research Fund, FranceMelanoma Research AllianceSFIVersus Arthritis, UKBreast Cancer Now, UKCancer Research UKNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKWellcomeRCNKWFGovernment of ItalyDamon Runyon Cancer Research FoundationVinnova, SwedenWorld Cancer Researh Fund, UK
Not available anywhere: 2
PD-L1 expression in peripheral T-cell lymphomas is not related to either PD-L1 gene amplification or rearrangements
R Manso, S Rodríguez-Perales, R Torres-Ruiz, C Santonja, ...
Leukemia & Lymphoma 62 (7), 1648-1656, 2021
Mandates: Government of Spain
Modeling Cancer Using CRISPR-Cas9 Technology
S Rodriguez-Perales, M Martinez-Lage, R Torres-Ruiz
Animal Models for the Study of Human Disease, 905-924, 2017
Mandates: Government of Spain
Available somewhere: 63
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system
R Torres, MC Martin, A Garcia, JC Cigudosa, JC Ramirez, ...
Nature communications 5 (1), 3964, 2014
Mandates: Government of Spain
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
O Calvete, P Martinez, P Garcia-Pavia, C Benitez-Buelga, ...
Nature communications 6 (1), 8383, 2015
Mandates: European Commission, Government of Spain
A faecal microbiota signature with high specificity for pancreatic cancer
E Kartal, TSB Schmidt, E Molina-Montes, S Rodríguez-Perales, J Wirbel, ...
Gut 71 (7), 1359-1372, 2022
Mandates: US National Institutes of Health, European Molecular Biology Laboratory …
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
B Oldrini, N Vaquero-Siguero, Q Mu, P Kroon, Y Zhang, M Galán-Ganga, ...
Nature communications 11 (1), 3883, 2020
Mandates: National Natural Science Foundation of China, Research Grants Council, Hong Kong
CRISPR/Cas9 for cancer therapy: hopes and challenges
M Martinez-Lage, P Puig-Serra, P Menendez, R Torres-Ruiz, ...
Biomedicines 6 (4), 105, 2018
Mandates: Government of Spain
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
S García-Silva, A Benito-Martín, L Nogués, A Hernández-Barranco, ...
Nature Cancer 2 (12), 1387-1405, 2021
Mandates: US National Institutes of Health, Banking Foundation "la Caixa", Government …
Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR/Cas9-mediated gene editing
J Bonafont, Á Mencía, M García, R Torres, S Rodríguez, M Carretero, ...
Molecular Therapy 27 (5), 986-998, 2019
Mandates: Government of Spain
Gain-of-function mutations in DNMT3A in patients with paraganglioma
L Remacha, M Currás-Freixes, R Torres-Ruiz, F Schiavi, R Torres-Pérez, ...
Genetics in Medicine 20 (12), 1644-1651, 2018
Mandates: Government of Spain
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
M Martinez-Lage, R Torres-Ruiz, P Puig-Serra, P Moreno-Gaona, ...
Nature communications 11 (1), 5060, 2020
Mandates: Banking Foundation "la Caixa", European Commission, Government of Spain
NHEJ-mediated repair of CRISPR-Cas9-induced DNA breaks efficiently corrects mutations in HSPCs from patients with fanconi anemia
FJ Román-Rodríguez, L Ugalde, L Álvarez, B Díez, MJ Ramírez, ...
Cell Stem Cell 25 (5), 607-621. e7, 2019
Mandates: Government of Spain
CRISPR-Cas9 technology: applications and human disease modelling
Guest Editors: Lu Xiao-Jie and Ji Li-Juan, R Torres-Ruiz, ...
Briefings in Functional Genomics 16 (1), 4-12, 2017
Mandates: Government of Spain
Efficient recreation of t (11; 22) EWSR1-FLI1+ in human stem cells using CRISPR/Cas9
R Torres-Ruiz, M Martinez-Lage, MC Martin, A Garcia, C Bueno, ...
Stem cell reports 8 (5), 1408-1420, 2017
Mandates: Government of Spain
Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling
B Oldrini, Á Curiel-García, C Marques, V Matia, Ö Uluçkan, ...
Nature communications 9 (1), 1466, 2018
Mandates: Banking Foundation "la Caixa", Government of Spain
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
B Diez, P Genovese, FJ Roman‐Rodriguez, L Alvarez, G Schiroli, ...
EMBO molecular medicine 9 (11), 1574-1588, 2017
Mandates: Government of Spain
Development refractoriness of MLL-rearranged human B cell acute leukemias to reprogramming into pluripotency
A Muñoz-López, D Romero-Moya, C Prieto, V Ramos-Mejía, ...
Stem cell reports 7 (4), 602-618, 2016
Mandates: UK Biotechnology and Biological Sciences Research Council, European …
Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
T Visnes, C Benítez-Buelga, A Cázares-Körner, K Sanjiv, BMF Hanna, ...
Nucleic acids research 48 (21), 12234-12251, 2020
Mandates: Swedish Research Council, European Commission, Research Council of Norway …
mTORC1 inactivation promotes colitis-induced colorectal cancer but protects from APC loss-dependent tumorigenesis
M Brandt, TP Grazioso, MA Fawal, KS Tummala, R Torres-Ruiz, ...
Cell Metabolism 27 (1), 118-135. e8, 2018
Mandates: Banking Foundation "la Caixa", Government of Spain
CRISPR-Cas9: a revolutionary tool for cancer modelling
R Torres-Ruiz, S Rodriguez-Perales
International Journal of Molecular Sciences 16 (9), 22151-22168, 2015
Mandates: Government of Spain
Publication and funding information is determined automatically by a computer program